“IMMUNE CHECKPOINT INHIBITORS IN SOLID TUMORS: MECHANISMS, CLINICAL EFFICACY, BIOMARKER-GUIDED PATIENT SELECTION, AND IMMUNE-RELATED ADVERSE EVENTS”. 2026. Journal of Multidisciplinary Sciences and Innovations 5 (03): 1709-14. https://doi.org/10.55640/.